tiprankstipranks
Kilitch Drugs (India) Limited (IN:KILITCH)
:KILITCH
India Market

Kilitch Drugs (India) Limited (KILITCH) Income Statement

Compare
0 Followers

Kilitch Drugs (India) Limited Income Statement

Last quarter (Q3 2023), Kilitch Drugs (India) Limited's total revenue was ₹317.94M, an increase of 6.08% from the same quarter last year. In Q3, Kilitch Drugs (India) Limited's net income was ₹29.09M. See Kilitch Drugs (India) Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 1.54B₹ 1.40B₹ 1.14B₹ 685.23M₹ 533.20M
Gross Profit
₹ 620.48M₹ 648.40M₹ 488.01M₹ 312.16M₹ 242.34M
Operating Expenses
₹ 412.43M₹ 508.25M₹ 398.75M₹ 274.65M₹ 257.21M
Depreciation and Amortization
₹ 33.50M₹ 35.51M₹ 24.66M₹ 19.86M₹ 19.99M
EBITDA
₹ 286.33M₹ 206.50M₹ 134.13M₹ 79.85M₹ 45.47M
Operating Income
₹ 208.05M₹ 148.60M₹ 100.16M₹ 41.34M₹ -8.44M
Other Income/Expenses
₹ -14.51M₹ -28.45M₹ -4.01M₹ 9.86M₹ 30.94M
Pretax Income
₹ 193.54M₹ 120.14M₹ 96.14M₹ 51.20M₹ 16.07M
Net Income
₹ 146.01M₹ 104.48M₹ 73.67M₹ 36.71M₹ 8.42M
Per Share Metrics
₹ ―₹ ―₹ ―₹ ―₹ ―
Basic EPS
₹ 9.17₹ 6.71₹ 4.73₹ 2.37₹ 0.55
Diluted EPS
₹ 9.17₹ 6.71₹ 4.73₹ 2.37₹ 0.55
Weighted Average Shares Outstanding
15.92M 15.58M 15.57M 15.48M 15.42M
Weighted Average Shares Outstanding (Diluted)
15.92M 15.58M 15.57M 15.48M 15.42M
Currency in INR

Kilitch Drugs (India) Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis